Utz Krug

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Klaus H. Metzeler, Tobias Herold, Maja Rothenberg‐Thurley et al. · Blood · 2016 · 523 citations · Full text

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms

Chantana Polprasert, Isabell Schulze, Mikkael A. Sekeres et al. · Cancer Cell · 2015 · 421 citations · Full text

Hematological Malignancy, Somatic Defects, Hematology +4

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Christoph Röllig, Hubert Serve, Andreas Hüttmann et al. · The Lancet Oncology · 2015 · 395 citations · Full text

Sorafenib Versus Placebo, Hematological Malignancy, Oncology +9

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Hubert Serve, Utz Krug, Ruth Wagner et al. · Journal of Clinical Oncology · 2013 · 309 citations · Full text

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

Utz Krug, Christoph Röllig, Anja Koschmieder et al. · The Lancet · 2010 · 302 citations

Hematological Malignancy, Prognostic Evaluation, Medicine +12